cap-100
Cap 100 is a drug used to treat Lymphocytic Leukemia, Chronic and SLL. Cap 100 is being actively studied in 1 study; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Catapult Therapeutics | Duke University | |
| Ohio State University | ||
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
- Lymphocytic Leukemia, Chronic
- SLL
- CAP-100
- Durham, North Carolina
- +1 more
2021-09-16
Sep 16, 2021